The effects of chronic high-dose morphine on microgliosis and the microglial transcriptome in rat spinal cord

Fredrik Hg Ahlström1,2, Hanna Viisanen1,2, Leena Karhinen1

  • 1Faculty of Medicine, Department of Pharmacology, University of Helsinki, Helsinki, Finland.

Molecular Pain
|June 7, 2023
PubMed

Insights

Chronic high-dose morphine in rats led to similar pain behaviors in males and females, with decreased spinal microglia staining and altered gene expression related to circadian rhythms and apoptosis.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Immunology

Background:

  • Opioids are effective for acute pain but chronic use causes tolerance and dependence.
  • Opioid-induced microglial activation is implicated in tolerance, potentially differing between sexes.
  • Microglial activation links to inflammation, circadian rhythm disruption, and neurotoxicity.

Purpose of the Study:

  • To investigate chronic morphine effects on pain behavior, spinal microglia, and neuronal staining.
  • To analyze the transcriptome of spinal microglia after long-term high-dose morphine administration.
  • To understand microglia's role in long-term high-dose opioid consequences.

Main Methods:

  • Administered increasing subcutaneous doses of morphine or saline to male and female rats.
  • Assessed thermal nociception using tail flick and hot plate tests.
  • Analyzed spinal cord samples for microglial (IBA1) and neuronal staining, and microglial transcriptome.

Main Results:

  • Male and female rats exhibited similar antinociceptive responses and tolerance to morphine.
  • Morphine administration decreased microglial IBA1 staining in the spinal cord in both sexes.
  • Differentially expressed genes in microglia included those related to circadian rhythm, apoptosis, and immune processes.

Conclusions:

  • Chronic high-dose morphine resulted in similar pain behaviors and decreased spinal microglia staining in both sexes.
  • Gene expression changes in spinal microglia involve circadian rhythm regulators (e.g., Per2, Per3, Dbp).
  • These findings highlight the need to consider microglial changes in long-term, high-dose opioid therapy.

Related Concept Videos